Table 1.
Classes of immunotherapy agents in oncology
| Active Immunotherapies | |
|---|---|
| Classes | Examples |
| Cancer vaccines | Sipuleucel‐T |
| Cytokines | Interleukin‐2, interferon‐α |
| Immunomodulatory mAbs | Nivolumab, ipilimumab, pembrolizumab |
| Passive immunotherapies | |
| Classes | Examples |
| Cell‐based therapies | Adoptive T‐cell therapy (e.g., TIL, TCR, CAR‐T) |
| Oncolytic viruses | T‐Vec |
| Bi‐ and multispecific antibodies | Blinatumomab |
| Tumor‐targeting mAbs | Rituximab |
mAbs, monoclonal antibodies; TIL, tumor infiltrating lymphocytes; TCR, T‐cell receptor; CAR‐T, chimeric antigen receptor T‐cell therapy; T‐Vec, Talimogene laherparepvec.